The FDA has requested updated labeling for COVID-19 vaccines, citing the risk of myocarditis, especially in young men.
Raluca Ioana Draghici
Health
www.shutterstock.com
Always see our news on Google
Myocarditis, a mild inflammation of the heart, has been identified as a complication of COVID-19 vaccines, and the FDA has asked to expand the warnings to include details about the risks. According to the new data, the risk of myocarditis is 8 cases per 1 million vaccinations, most common in men ages 12 to 24. Although the cases are less severe than the myocarditis caused by COVID-19, the updated labeling has stirred controversy, especially in the context of new anti-vaccination counselors appointed by the health secretary. Experts suggest that the current approach is wrong and that people predisposed to myocarditis should be investigated.
Sources
Latest News
17:53
Two migrants were rescued after drifting for two weeks in the Mediterranean Sea, while 17 people from the same boat went missing.
17:43
ITA Airways introduces the 'Large Pet Friendly' service, allowing dogs up to 30 kg to travel in the cabin on domestic flights.
17:29
Austria recorded on Tuesday a new temperature record of 40.8°C
17:23
The heat waves in Italy have led to the death of five agricultural workers, including a 19-year-old Romanian.
17:19
EBA recommends postponing the controls on the new rules that separate the trading activities of banks from the rest of their operations.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
